semaglutide mash pdufa Novo Nordisk's Wegovy gets accelerated US approval for liver disease Wegovy Gets F.D.A. Approval for
Description
Taking semaglutide for obesity treatment has an incidence rate of NAION seven times higher than with other medications

We could have a medication that works 100% of the time, but only causes 1-2 pounds of weight loss

L., Simoes Torpey H

Typical symptoms of stroke include sudden unilateral weakness, numbness or loss of vision, diplopia, changes in speech, ataxia, and non-orthogonal vertigo (77)

For this reason, these medications are often prescribed for managing type 2 diabetes or obesity

[10] [11] While the absolute incidence remains uncertain, these reports have prompted heightened awareness and protocol modifications
